Algorae Pharmaceuticals PE Ratio Insights

Algorae Pharmaceuticals Ltd (LVCLY)

0.0246 -0.01 (-17.73%) USD | OTCM | May 17, 16:00

PE Ratio Chart

Historical PE Ratio Data

View and export this data back to 2011. Upgrade now.

Date	Value
July 02, 2013	1.620
July 01, 2013	1.620
June 30, 2013	1.620
June 28, 2013	1.620
June 27, 2013	1.620
June 26, 2013	1.620
June 25, 2013	1.755
June 24, 2013	1.755
June 21, 2013	1.710
June 20, 2013	1.654
June 19, 2013	1.958
June 18, 2013	1.958
June 17, 2013	1.800
June 14, 2013	1.953
June 13, 2013	1.953
June 12, 2013	1.953
June 11, 2013	1.953
June 10, 2013	1.953
June 07, 2013	1.868
June 06, 2013	1.868
June 05, 2013	2.025
June 04, 2013	1.913
June 03, 2013	1.890
May 31, 2013	1.890
May 30, 2013	1.890

Date	Value
May 29, 2013	1.877
May 28, 2013	1.958
May 24, 2013	1.958
May 23, 2013	1.971
May 22, 2013	1.890
May 21, 2013	1.890
May 20, 2013	1.924
May 17, 2013	2.079
May 16, 2013	1.922
May 15, 2013	1.953
May 14, 2013	2.066
May 13, 2013	2.003
May 10, 2013	1.890
May 09, 2013	1.958
May 08, 2013	1.958
May 07, 2013	1.890
May 06, 2013	2.025
May 03, 2013	2.025
May 02, 2013	1.917
May 01, 2013	1.917
April 30, 2013	1.917
April 29, 2013	1.890
April 26, 2013	1.890
April 25, 2013	1.935
April 24, 2013	1.921

Price to Earnings Ratio (PE Ratio) Definition

The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.

Read full definition.

PE Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

PE Ratio Benchmarks

Alterity Therapeutics Ltd	--
Kazia Therapeutics Ltd	--
Immutep Ltd	--
Opthea Ltd	--
Mesoblast Ltd	--

PE Ratio Related Metrics

Price	0.0246
Market Cap	4.087M